Загрузка...
New and emerging therapies for acute and chronic graft versus host disease
Graft versus host disease (GVHD) remains a major cause of morbidity and mortality following allogeneic hematopoietic stem-cell transplantation (HSCT). Despite the use of prophylactic GVHD regimens, a significant proportion of transplant recipients will develop acute or chronic GVHD following HSCT. C...
Сохранить в:
| Опубликовано в: : | Ther Adv Hematol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5753923/ https://ncbi.nlm.nih.gov/pubmed/29317998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620717741860 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|